Dipatimenti Yapadziko Lonse

Pa June 11, Kelun-Biotech adalengeza kuti kampani yake yopanga mankhwala a TROP2 ADC sac-TMT (佳泰莱) payokha, pamodzi ndi PD-L1 monoclonal antibody tagitanlimab (科泰莱), yapatsidwa Breakthrough Therapy Designation (BTD) ndi Center for Drug Evaluation (CDE) ya National Med...Werengani zambiri»

Pa Meyi 29, bungwe la National Medical Products Administration (NMPA) linavomereza kugulitsidwa kwa Zanidatamab, komwe kunaperekedwa ndi BeiGene, kuti kuchiritsidwe odwala omwe ali ndi khansa ya m'mimba yosachiritsika kapena yofalikira m'matumbo (BTC) omwe adalandirapo chithandizo chamankhwala amthupi ndipo ali ndi HER2 yapamwamba...Werengani zambiri»

Pa Juni 04, 2025, Akeso adalengeza kuti National Medical Products Administration (NMPA) yavomereza mankhwala oyamba a PD-1/CTLA-4 bispecific antibody a kampaniyo, cadonilimab, kuti agwiritsidwe ntchito pochiza khansa ya pachibelekero yomwe ikupitilizabe, yobwerezabwereza, kapena yofalikira, pamodzi ndi platinu...Werengani zambiri»

Pa Meyi 29, bungwe la National Medical Products Administration (NMPA) linavomereza mankhwala a HER2-target antibody-drug conjugate (ADC) trastuzumab rezetecan (SHR-A1811) kuti agulitsidwe. Akuwonetsedwa ngati mankhwala amodzi ochizira odwala akuluakulu omwe ali ndi matenda osachiritsika omwe angayambitse matendawa m'deralo kapena omwe ali ndi matenda enaake ...Werengani zambiri»

Pa Meyi 21, 2025, InnoCare Pharma yalengeza kuti China National Medical Products Administration (NMPA) yavomereza Minjuvi® (tafasitamab), mankhwala a Fc-modified cytolytic CD19 omwe amalimbana ndi monoclonal antibody, pamodzi ndi lenalidomide, kutsatiridwa ndi Minjuvi monotherapy, kuti agwiritsidwe ntchito pochiza matenda a shuga.Werengani zambiri»

Pa Meyi 22, 2025, Allist Pharmaceuticals idalengeza kuti mankhwala ake atsopano a Airuikai (Glecirasib Citrate Tablets), omwe ndi choletsa cha KRAS-G12C, avomerezedwa mwalamulo kuti ayambe kugwiritsidwa ntchito pamsika ndi National Medical Products Administration (NMPA). Chivomerezochi chimalola Airuikai kugwiritsidwa ntchito pochiza...Werengani zambiri»

Pa Meyi 22, 2025, Kelun Bio adalengeza kuti pempho la chizindikiro chatsopano cha trophoblast cell surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, yomwe imadziwikanso kuti SKB264/MK – 2870) (®) lavomerezedwa ndi Center for Drug Evaluation (...Werengani zambiri»

Mu Nkhondo Yaikulu Yolimbana ndi Khansa, Zida Zatsopano Zolimbana ndi Khansa Zikubuka Mosalekeza, Kubweretsa Chiyembekezo Chatsopano kwa Odwala Mu nkhondo yayitali pakati pa anthu ndi khansa, zida zatsopano zotsutsana ndi khansa zikutuluka chimodzi ndi chimodzi, kubweretsa chiyembekezo chatsopano kwa odwala. Monga njira yatsopano yowala...Werengani zambiri»

Mu 2021, wodwala khansa ya kapamba wazaka 67 adapanga chozizwitsa chachipatala. Atachitidwa opaleshoni, kulandira mankhwala a chemotherapy kangapo, komanso kulephera kwa chithandizo cha TIL, mayeso azachipatala a chithandizo cha maselo a TCR-T omwe adachita nawo adapangitsa kuti metastases ya m'mapapo ichepe ndi 72% mkati mwa miyezi 6...Werengani zambiri»

Pa Meyi 12, 2025, CARsgen yalengeza zambiri zoyambirira zachipatala za CT0596, CAR-T yolumikizidwa ndi BCMA yopangidwa pogwiritsa ntchito nsanja ya THANK-u Plus™. CT0596 ikuwunikidwa mu kafukufuku woyambirira wazachipatala wofufuza za myeloma yobwereranso/yosasinthika (R/R MM) kapena yobwereranso/yosasinthika...Werengani zambiri»

Pa Meyi 9, 2025, Hansoh Pharmaceutical idalengeza kuti chizindikiro chatsopano cha Ameile (mapiritsi a almonertinib mesylate) chavomerezedwa kuti chigulitsidwe. Chizindikiro chatsopanochi ndi cha chithandizo chothandizira odwala akuluakulu omwe ali ndi khansa ya m'mapapo yopanda maselo ang'onoang'ono (NSCLC) omwe zotupa zawo zili ndi epidermal growth factor re...Werengani zambiri»

Pa Meyi 1, 2025, Hansoh Pharmaceutical yalengeza kuti mankhwala opangidwa okha a B7-H4-target antibody-drug conjugate (ADC) HS-20089 a Gululi kuti agwiritsidwe ntchito jakisoni avomerezedwa kuti aphatikizidwe ngati mankhwala opangidwa ndi Breakthrough-Therapy ndi National Medical Products Administration (NMPA) ya ku China, omwe ali ndi...Werengani zambiri»